140. ドラベ症候群 Dorabe syndrome Clinical trials / Disease details


臨床試験数 : 104 薬物数 : 61 - (DrugBank : 14) / 標的遺伝子数 : 48 - 標的パスウェイ数 : 63

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-jRCTs041190116
17/02/202017/02/20203D gait analysis and L-DOPA in Dravet syndrome.3D gait analysis and effectiveness of L-DOPA on pathological gait in Dravet syndrome. Dravet syndrome(severe myoclonic epilepsy in infant)
Dravet syndrome, severe myoclonic epilepsy in infant;D004831
Arm A:0) 3D gait analysis and RS-fMRI before medication 1) levodopa/carbidopa(5mg/kg/day or 300mg/day(more than 60kg)) given orally during 4-6weeks 2) second 3D gait analysis and RS-fMRI 3) reduce and stop medication durring 4weeks, no medication during 4-6weeks 4)third 3D gait analysis
Arm B:0) 3D gait analysis and RS-fMRI before medication 1) 4-6weeks with no medication 2) second 3D gait analysis 3) levodopa/carbidopa given orally during 4-6weeks 4)third 3D gait analysis and second RS-fMRI
Natsume JunNULLRecruiting>= 6age oldNot applicableBoth20Phase 4Japan